Modulation of metabolic, inflammatory, fibrotic, and cell death pathways by resmetirom in metabolic dysfunction-associated steatohepatitis (MASH): a transcriptomic profiling study
Crossref DOI link: https://doi.org/10.1038/s41401-026-01772-2
Published Online: 2026-02-19
Published Print: 2026-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
He, Chen-yang
Wang, Zhi-hua
Weng, Jian-ping
Strijdom, Hans
Xu, Suo-wen
Text and Data Mining valid from 2026-02-19
Version of Record valid from 2026-02-19
Article History
Received: 16 December 2025
Accepted: 2 February 2026
First Online: 19 February 2026
Competing interests
: The authors declare no competing interests.